Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome
Stephen Robinson(Intel (United States)), Jakob Passweg(University Hospital of Basel), N. Russell(Nottingham City Hospital), Andrew R. Pettitt(University of Liverpool), Gèrard Socié(Hôpital Saint-Louis), Rodrigo Martino(Universitat Autònoma de Barcelona), Fiona Clarke(Burnley General Teaching Hospital), Gordon Cook(University of Leeds), Alberto Bosi(Azienda Ospedaliero-Universitaria Careggi), J. Maertens(KU Leuven), Carmen Canals(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), A Iriondo(Hospital de Sant Pau), Francesca Bonifazi(University of Bologna), Almalina Bacigalupo(Ospedale Policlinico San Martino), M. Michallet(Hospices Civils de Lyon), Effie Liakopoulou(The Christie Hospital), Norbert Schmitz(University Hospital Münster), Dolores Caballero(Complejo Hospitalario de Salamanca)
Cited by 169
Related Papers
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k